Justin Shakespeare

Justin Shakespeare serves as the Vice President and Global Commercial Head of Oncology and Global Commercial Operations at Gilead Sciences, where responsibilities include leading the commercial development of the oncology portfolio and managing global commercial operations. With extensive experience in oncology and commercial strategy, Justin previously held multiple senior positions at Amgen, including Vice President of US Sales and Marketing for the Otezla franchise and Global Product General Manager for the Acute Myeloid Leukemia pipeline. Justin's career began at Merck and Rhone-Poulenc Rorer, and education includes an MBA from Villanova University and a BSBA in Marketing Management from the University of Arkansas. Additionally, Justin is a National Board Member for Kesem.